Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Coupling of Immunostimulants to Live Cells through Metabolic Glycoengineering and Bioorthogonal Click Chemistry.

Mongis A, Piller F, Piller V.

Bioconjug Chem. 2017 Apr 19;28(4):1151-1165. doi: 10.1021/acs.bioconjchem.7b00042. Epub 2017 Mar 28.

PMID:
28297599
2.

Metabolic Glyco-Engineering in Eukaryotic Cells and Selected Applications.

Piller F, Mongis A, Piller V.

Methods Mol Biol. 2015;1321:335-59. doi: 10.1007/978-1-4939-2760-9_23.

PMID:
26082233
3.

Combining triazole ligation and enzymatic glycosylation on solid phase simplifies the synthesis of very long glycoprotein analogues.

Galibert M, Piller V, Piller F, Aucagne V, Delmas AF.

Chem Sci. 2015 Jun 1;6(6):3617-3623. doi: 10.1039/c5sc00773a. Epub 2015 Apr 14.

4.

Changes in metabolic chemical reporter structure yield a selective probe of O-GlcNAc modification.

Chuh KN, Zaro BW, Piller F, Piller V, Pratt MR.

J Am Chem Soc. 2014 Sep 3;136(35):12283-95. doi: 10.1021/ja504063c. Epub 2014 Aug 25.

5.

Respiratory mechanics in COPD patients who failed non-invasive ventilation: role of intrinsic PEEP.

Antonaglia V, Ferluga M, Capitanio G, Lucangelo U, Piller F, Roman-Pognuz E, Biancardi B, Caggegi GD, Zin WA.

Respir Physiol Neurobiol. 2012 Oct 15;184(1):35-40. doi: 10.1016/j.resp.2012.07.009. Epub 2012 Aug 2.

PMID:
22877584
6.

MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.

Solatycka A, Owczarek T, Piller F, Piller V, Pula B, Wojciech L, Podhorska-Okolow M, Dziegiel P, Ugorski M.

Glycobiology. 2012 Aug;22(8):1042-54. doi: 10.1093/glycob/cws075. Epub 2012 Apr 25.

PMID:
22534569
7.

Evaluation of analogues of GalNAc as substrates for enzymes of the mammalian GalNAc salvage pathway.

Pouilly S, Bourgeaux V, Piller F, Piller V.

ACS Chem Biol. 2012 Apr 20;7(4):753-60. doi: 10.1021/cb200511t. Epub 2012 Feb 9.

PMID:
22276930
8.

Metabolic glycoengineering through the mammalian GalNAc salvage pathway.

Pouilly S, Piller V, Piller F.

FEBS J. 2012 Feb;279(4):586-98. doi: 10.1111/j.1742-4658.2011.08448.x. Epub 2012 Jan 13.

9.

Functionalization of heterocyclic compounds using polyfunctional magnesium and zinc reagents.

Knochel P, Schade MA, Bernhardt S, Manolikakes G, Metzger A, Piller FM, Rohbogner CJ, Mosrin M.

Beilstein J Org Chem. 2011;7:1261-77. doi: 10.3762/bjoc.7.147. Epub 2011 Sep 13.

10.

Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients.

Azzopardi N, Lecomte T, Ternant D, Boisdron-Celle M, Piller F, Morel A, Gouilleux-Gruart V, Vignault-Desvignes C, Watier H, Gamelin E, Paintaud G.

Clin Cancer Res. 2011 Oct 1;17(19):6329-37. doi: 10.1158/1078-0432.CCR-11-1081. Epub 2011 Sep 27.

11.

Preparation of functionalized cyclic enol phosphates by halogen-magnesium exchange and directed deprotonation reactions.

Piller FM, Bresser T, Fischer MK, Knochel P.

J Org Chem. 2010 Jul 2;75(13):4365-75. doi: 10.1021/jo100763f.

PMID:
20527975
12.

Preparation of highly functionalized alkylzinc halides from alkyl bromides using Mg, ZnCl2 and LiCl.

Blümke TD, Piller FM, Knochel P.

Chem Commun (Camb). 2010 Jun 21;46(23):4082-4. doi: 10.1039/c001845g. Epub 2010 Apr 9.

PMID:
20379592
13.

An enzyme-linked immunosorbent assay for therapeutic drug monitoring of cetuximab.

Cézé N, Ternant D, Piller F, Degenne D, Azzopardi N, Dorval E, Watier H, Lecomte T, Paintaud G.

Ther Drug Monit. 2009 Oct;31(5):597-601. doi: 10.1097/FTD.0b013e3181b33da3.

PMID:
19730278
14.

Preparation of polyfunctional arylmagnesium, arylzinc, and benzylic zinc reagents by using magnesium in the presence of LiCl.

Piller FM, Metzger A, Schade MA, Haag BA, Gavryushin A, Knochel P.

Chemistry. 2009 Jul 20;15(29):7192-202. doi: 10.1002/chem.200900575.

PMID:
19544505
15.

Regio- and chemoselective synthesis of fully substituted thiophenes.

Piller FM, Knochel P.

Org Lett. 2009 Jan 15;11(2):445-8. doi: 10.1021/ol802513q.

PMID:
19099513
16.

Polyfunctional benzylic zinc chlorides by the direct insertion of magnesium into benzylic chlorides in the presence of LiCl and ZnCl2.

Metzger A, Piller FM, Knochel P.

Chem Commun (Camb). 2008 Nov 30;(44):5824-6. doi: 10.1039/b812396a. Epub 2008 Oct 1.

PMID:
19009094
17.

Convenient preparation of polyfunctional aryl magnesium reagents by a direct magnesium insertion in the presence of LiCl.

Piller FM, Appukkuttan P, Gavryushin A, Helm M, Knochel P.

Angew Chem Int Ed Engl. 2008;47(36):6802-6. doi: 10.1002/anie.200801968. No abstract available.

PMID:
18663703
18.

Efficient enzymatic glycosylation of peptides and oligosaccharides from GalNAc and UTP.

Bourgeaux V, Cadène M, Piller F, Piller V.

Chembiochem. 2007 Jan 2;8(1):37-40. No abstract available.

PMID:
17111441
19.

Synthesis and biological evaluation of a multiantigenic Tn/TF-containing glycopeptide mimic of the tumor-related MUC1 glycoprotein.

Cremer GA, Bureaud N, Piller V, Kunz H, Piller F, Delmas AF.

ChemMedChem. 2006 Sep;1(9):965-8. No abstract available.

PMID:
16952141
20.

Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.

Freire T, Lo-Man R, Piller F, Piller V, Leclerc C, Bay S.

Glycobiology. 2006 May;16(5):390-401. Epub 2006 Jan 31.

PMID:
16449349
21.

Two-step enzymatic synthesis of UDP-N-acetylgalactosamine.

Bourgeaux V, Piller F, Piller V.

Bioorg Med Chem Lett. 2005 Dec 15;15(24):5459-62. Epub 2005 Oct 3.

PMID:
16203137
22.

Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter.

Martinez-Duncker I, Dupré T, Piller V, Piller F, Candelier JJ, Trichet C, Tchernia G, Oriol R, Mollicone R.

Blood. 2005 Apr 1;105(7):2671-6. Epub 2004 Dec 2.

23.

Synthesis of branched oxime-linked peptide mimetics of the MUC1 containing a universal T-helper epitope.

Cremer GA, Bureaud N, Lelièvre D, Piller V, Piller F, Delmas A.

Chemistry. 2004 Dec 3;10(24):6353-60.

PMID:
15532020
24.

Characterization of the UDP-N-acetylgalactosamine binding domain of bovine polypeptide alphaN-acetylgalactosaminyltransferase T1.

Duclos S, Da Silva P, Vovelle F, Piller F, Piller V.

Protein Eng Des Sel. 2004 Aug;17(8):635-46. Epub 2004 Sep 17.

PMID:
15377782
25.

Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter.

Dalziel M, Dall'Olio F, Mungul A, Piller V, Piller F.

Eur J Biochem. 2004 Sep;271(18):3623-34.

26.

Synthesis and biological evaluation of new UDP-GalNAc analogues for the study of polypeptide-alpha-GalNAc-transferases.

Busca P, Piller V, Piller F, Martin OR.

Bioorg Med Chem Lett. 2003 Jun 2;13(11):1853-6.

PMID:
12749883
27.

A heat labile soluble factor from Bacteroides thetaiotaomicron VPI-5482 specifically increases the galactosylation pattern of HT29-MTX cells.

Freitas M, Cayuela C, Antoine JM, Piller F, Sapin C, Trugnan G.

Cell Microbiol. 2001 May;3(5):289-300.

PMID:
11298652
28.

High levels of ceruloplasmin in the serum of transgenic mice developing hepatocellular carcinoma.

Pousset D, Piller V, Bureaud N, Piller F.

Eur J Biochem. 2001 Mar;268(5):1491-9.

29.

Neutrophil polarity and locomotion are associated with surface redistribution of leukosialin (CD43), an antiadhesive membrane molecule.

Seveau S, Keller H, Maxfield FR, Piller F, Halbwachs-Mecarelli L.

Blood. 2000 Apr 15;95(8):2462-70.

30.

Enzymatic glycosylation of contulakin-G, a glycopeptide isolated from Conus venom, with a mammalian ppGalNAc-transferase.

Craig AG, Park M, Fischer WH, Kang J, Compain P, Piller F.

Toxicon. 2001 Jun;39(6):809-15.

PMID:
11137540
31.

Molecular cloning of a putative alpha3-fucosyltransferase from Schistosoma mansoni.

Trottein F, Mollicone R, Fontaine J, de Mendonça R, Piller F, Pierce R, Oriol R, Capron M.

Mol Biochem Parasitol. 2000 Apr 15;107(2):279-87.

PMID:
10779604
32.
33.

Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.

Pousset D, Piller V, Bureaud N, Monsigny M, Piller F.

Cancer Res. 1997 Oct 1;57(19):4249-56.

34.
35.

The expression of carbohydrate blood group antigens correlates with heat resistance.

Ménoret A, Otry C, Labarrière N, Breimer ME, Piller F, Meflah K, Le Pendu J.

J Cell Sci. 1995 Apr;108 ( Pt 4):1691-701.

36.

An anti-B cell autoantibody from Wiskott-Aldrich syndrome which recognizes i blood group specificity on normal human B cells.

Grillot-Courvalin C, Brouet JC, Piller F, Rassenti LZ, Labaume S, Silverman GJ, Silberstein L, Kipps TJ.

Eur J Immunol. 1992 Jul;22(7):1781-8.

PMID:
1623923
37.

Biosynthesis of the blood group Pk and P1 antigens by human kidney microsomes.

Bailly P, Piller F, Gillard B, Veyrières A, Marcus D, Cartron JP.

Carbohydr Res. 1992 Apr 10;228(1):277-87.

PMID:
1516091
38.

X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers.

De Saint-Basile G, Schlegel N, Caniglia M, Le Deist F, Kaplan C, Lecompte T, Piller F, Fischer A, Griscelli C.

Ann Hematol. 1991 Aug;63(2):107-10.

PMID:
1912030
39.

Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome.

Piller F, Le Deist F, Weinberg KI, Parkman R, Fukuda M.

J Exp Med. 1991 Jun 1;173(6):1501-10.

40.
41.
42.
43.
44.

O-glycosylation of leukosialin in K562 cells. Evidence for initiation and elongation in early Golgi compartments.

Piller V, Piller F, Klier FG, Fukuda M.

Eur J Biochem. 1989 Jul 15;183(1):123-35.

46.

Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis.

Piller F, Piller V, Fox RI, Fukuda M.

J Biol Chem. 1988 Oct 15;263(29):15146-50.

47.
48.

Characterization and specific assay for a galactoside beta-3-galactosyltransferase of human kidney.

Bailly P, Piller F, Cartron JP.

Eur J Biochem. 1988 Apr 15;173(2):417-22.

49.

Identification of UDP-galactose: lactose (lactosylceramide) alpha-4 and beta-3 galactosyltransferases in human kidney.

Bailly P, Piller F, Cartron JP, Leroy Y, Fournet B.

Biochem Biophys Res Commun. 1986 Nov 26;141(1):84-91.

PMID:
3099784
50.

Isolation and characterization of an N-acetylgalactosamine specific lectin from Salvia sclarea seeds.

Piller V, Piller F, Cartron JP.

J Biol Chem. 1986 Oct 25;261(30):14069-75.

Supplemental Content

Loading ...
Support Center